<DOC>
	<DOCNO>NCT01951105</DOCNO>
	<brief_summary>This study aim determine early treatment Carbidopa/Levodopa Naproxen individual sub-acute back pain ( SBP ) associate change block transition chronic back pain ( CBP ) .</brief_summary>
	<brief_title>Effect L-dopa In Subacute Back Pain Population</brief_title>
	<detailed_description>The transition acute low back pain chronic low back pain show result change brain circuitry . Learning mechanism give rise transition acute chronic pain render pain become emotional . The aim study explore idea persistent pain , follow incite injury , lead aversive learn signal reorganizes brain chronic pain state . We hypothesize block emotional/motivational learning response trigger peripheral nerve injury critical time window decrease probability transition chronic pain . The primary hypothesis test study early treatment Carbidopa/Levodopa Naproxen individual sub-acute back pain ( SBP ) decrease relate reorganization block transition chronic back pain ( CBP ) . This do 6 month , double-blind , randomize , placebo-controlled , three-arm , parallel-group trial pharmacological treatment Carbidopa/Levodopa individual ( N = 200 ) sub-acute back pain ( SBP ) . A baseline MRI scan use determine subject 's pain type group assignment . Individuals recover sub-acute back pain observe 6 month . Individuals persist sub-acute back pain randomize receive either 12 week Carbidopa/Levodopa plus naproxen placebo plus naproxen . The main outcome measurement result MRI scan baseline final visit , assessment back pain NRS pain scale , well pain assessment self-reported questionnaire .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Male female , age 18 year , ( racial/ethnic restriction ) Must history low back pain minimum 4 week maximum 12 week sign symptom radiculopathy : positive straight leg raise test dermatomal radiation and/or myotomal weakness and/or reflex asymmetry ; pain must radiate buttock Must high risk phenotype chronification back pain ( evaluated baseline T1MRI , DTIMRI , fMRI scan ) Must average pain score 5 day period ( average ~15 measure smartphone app ) immediately precede baseline visit â‰¥ 5 ( 010 NRS ) baseline visit Must willing read able understand instruction well PROs Must generally stable health Must sign inform consent document complete explanation study document understand purpose study , procedure undertake , possible benefit , potential risk , willing participate Previous ( distinct ) episodes back pain onset ( 3 distinct episode back pain lasting total 4 week ) previous year Evidence rheumatoid arthritis , ankylose spondylitis , acute vertebral fracture , chronic spinal stenosis , prior back surgery history tumor spine Low back pain associated systemic sign symptom , e.g. , fever , chill Other comorbid chronic pain condition fibromyalgia neuropathic pain secondary diabetes postherpes zoster Chronic neurologic condition , include Parkinson 's disease , Alzheimer 's disease , condition associate dementia Significant medical disease congestive heart failure , coronary peripheral vascular disease , chronic obstructive lung disease , malignancy Diabetes Type I Type II History glaucoma narrow angle glaucoma Presence undiagnosed skin lesion history melanoma Presence severe cardiovascular pulmonary disease , bronchial asthma , renal , hepatic endocrine disease History myocardial infarction residual cardiac arrhythmia History gastrointestinal bleeding peptic ulcer Diagnosis current depression ( assessed via BDI , total &gt; 28 exclude ) psychiatric disorder require treatment , diagnosis previous 6 month Use therapeutic dos antidepressant medication ( i.e. , tricyclic antidepressant , SSRIs , SNRIs ; low dos use even sleep allow dose change ) Current use recreational drug recent history alcohol abuse ( pattern drink social , financial physical consequence ) drug abuse Any change medication back pain last 30 day High dose opioid prophylaxis , define &gt; 50mg morphine equivalent/day Use MAOIs , currently within past 2 week Prior use Levodopa Use follow drug : bromocryptine , linezolid , metoclopramide , phenothiazine , promethazine/codeine , isoniazid , rifampin , pyrazinamide Oral iron supplementation Contraindications use study product , base following : Hypersensitivity Carbidopa/Levodopa constituent Carbidopa/Levodopa capsule Hypersensitivity lactose constituent placebo capsule Hypersensitivity Naproxen constituent Naproxen capsule Hypersensitivity Acetaminophen constituent Acetaminophen tablet Currently take Levodopa dopaminergic drug Involvement litigation regard back pain disability claim receive workman 's compensation seek either result low back pain In judgment investigator , unable unwilling follow protocol instruction Intraaxial implant ( e.g . spinal cord stimulators pump ) All exclusion criterion MR safety : metallic implant , pacemaker , brain skull abnormality , tattoo large body part , claustrophobia Pregnancy inability use effective method birth control sexually active men woman take study drug one week thereafter . Barrier contraceptive ( condom diaphragm ) spermicide , intrauterine device ( IUD 's ) , hormonal contraceptive , oral contraceptive pill , surgical sterilization , complete abstinence example effective method contraception . Following laboratory abnormality : liver function test ( SGOT/SGPT ) great twice upper limit normal ; unexplained anemia ( Hgb &lt; 9 g/dL ) ; evidence renal insufficiency ( creatinine &gt; upper limit normal ) abnormality principal investigator feel put subject risk study History chronic opioid use pain management . Any medical condition investigator 's judgment may prevent individual completing study put individual undue risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Subacute</keyword>
	<keyword>Back</keyword>
	<keyword>Pain</keyword>
	<keyword>Brain</keyword>
	<keyword>MRI</keyword>
</DOC>